Mechanistic characterizations of redox regulations and functions of Arf and Rho families
Mechanistic characterizations of redox regulations and functions of Arf and Rho families
批准号:
10796624
负责人:
Jongyun Heo
金额:
$44.92万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-15 至 2026-08-31
关键词:
BindingBiochemicalBiochemistryBiological AssayCardiovascular DiseasesCell physiologyCellsCellular biologyCharacteristicsClassificationCommunitiesComplexComplicationDevelopmentDiseaseDissociationDrug ControlsEducationEventFamilyGTP BindingGoalsGrantGuanine Nucleotide Dissociation InhibitorsGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesImmuneImmune System DiseasesInvadedInvestigationKineticsKnowledgeLinkLiteratureMechanicsMembrane Protein TrafficMethodsMolecularMonomeric GTP-Binding ProteinsMotivationMutagenesisNucleotidesOxidation-ReductionPharmaceutical PreparationsPlayPropertyProtein FamilyProteinsRegulationResearchResearch PersonnelRespiratory BurstRoleRunningSignal TransductionSpecific qualifier valueSuperoxidesTherapeuticTherapeutic InterventionVacuumanaloganalytical methodbasedesensitizationgraduate studentinnovationinsightinterdisciplinary approachnovelnovel therapeutic interventionnucleotide analogprotein functionresponserhorho GTP-Binding Proteinstherapeutically effectivetherapy developmentundergraduate student
中文摘要
项目总结:
英文摘要
Project Summary:
Small GTPases play critical roles in cellular functions. They can be classified into several groups, including
the Arf, Rab, Ras, Rho, and Ran families of proteins. The redox regulations and functions of the Arf families of
small GTPases are unknown. The redox regulations and functions of the Rho families of small GTPases are only
partly known. Without knowing them, the development of effective therapeutics for diseases associated with
them is impractical. One long-term objective of this project is to understand the redox-dependent regulations
and functions of these proteins. Another objective is to develop therapeutic interventions for these diseases.
This objective includes the identification of the novel redox inert nucleotides that seem to target the redox-
sensitive Arf and Rho proteins to block their redox responses.
To achieve these goals, the previously unknown redox-sensitive motifs found in the Arf families of proteins
will be characterized by using a multidisciplinary approach that includes mutagenesis-based redox
biochemistry with novel mechanism-based nucleotide analogs as well as mass spectrometric, EPR
spectroscopic, and cell biology methods. The multidisciplinary approach will also be used to refine and
characterize previously unknown redox-sensitive motifs found in Rho proteins. The characterizations gained by
using mutagenesis-based redox biochemistry and cell biology as well as other analytical methods will identify
the unprecedented regulatory features and redox response properties of the new and refined redox-sensitive
motifs found in Arf and Rho GTPases. The feature characteristics of these redox motifs in these proteins will
then be classified based on their novel redox response properties. These classifications will further allow a
systematic mechanistic investigation of the detailed redox control and action of these redox motifs in these
small GTPases. This systematic mechanistic study will then specify the regulations of and mechanisms of the
actions of the new and refined redox-sensitive motifs found in the Arf and Rho families of small GTPases.
Furthermore, the redox biochemical analysis of this multidisciplinary approach includes the use of nucleotide
analogs that are novel redox-inert nucleotides. The use of these analogs is not only to inspect the mechanisms
of the actions of these redox motifs in the small GTPases but also to provide insight into a novel therapeutic
strategy in which a redox desensitization of these motifs alleviates or terminates diseases associated with the
unchecked redox response of these motifs in the small GTPases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determination of the mechanism of the immunosuppressive effects of thiopurines
-
批准号:8290672
-
项目类别:
-
资助金额:$44.03万
-
财政年份:2012
-
负责人:Jongyun Heo
-
依托单位:
海外基金